(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At ~~November 28, 2022,~~December 4, 2023, the registrant had ~~36,091,673~~35,599,426 shares of common stock outstanding.


	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
	October 29, 2022			October 30, 2021			October 29, 2022			October 30, 2021			October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	315.9		$	295.5		$	598.3		$	583.3		$	288.0		$	315.9		$	577.7		$	598.3

Cost of products sold		241.8			226.3			462.4			442.4			235.7			241.8			471.4			462.4

Gross profit		74.1			69.2			135.9			140.9			52.3			74.1			106.3			135.9

Selling and administrative expenses		36.6			31.2			71.9			64.0			40.9			36.6			85.4			71.9
Goodwill impairment														56.5			—			56.5			—
Amortization of intangibles		4.7			4.8			9.4			9.6			6.2			4.7			11.9			9.4

Income from operations		32.8			33.2			54.6			67.3
(Loss) income from operations														(51.3	)		32.8			(47.5	)		54.6

Interest expense, net		0.5			1.1			0.5			2.2			4.4			0.5			7.2			0.5
Other income, net		(1.1	)		(0.9	)		(5.2	)		(2.7	)		(0.2	)		(1.1	)		(0.2	)		(5.2	)

Income before income taxes		33.4			33.0			59.3			67.8
Pre-tax (loss) income														(55.5	)		33.4			(54.5	)		59.3

Income tax expense		5.8			5.5			10.2			11.2
Income tax (benefit) expense														(0.2	)		5.8			(0.1	)		10.2
Net (loss) income														(55.3	)		27.6			(54.4	)		49.1
Net income attributable to redeemable noncontrolling interest														—			—			—			—

Net income	$	27.6		$	27.5		$	49.1		$	56.6
Net (loss) income attributable to Methode													$	(55.3	)	$	27.6		$	(54.4	)	$	49.1

Basic and diluted income per share:
(Loss) income per share attributable to Methode:
Basic	$	0.76		$	0.73		$	1.35		$	1.50		$	(1.55	)	$	0.76		$	(1.52	)	$	1.35
Diluted	$	0.75		$	0.72		$	1.33		$	1.48		$	(1.55	)	$	0.75		$	(1.52	)	$	1.33

Cash dividends per share	$	0.14		$	0.14		$	0.28		$	0.28		$	0.14		$	0.14		$	0.28		$	0.28


	October 29, 2022			April 30, 2022			October 28, 2023			April 29, 2023
	(unaudited)						(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	129.6		$	172.0		$	122.5		$	157.0
Accounts receivable, net		312.8			273.3			292.3			314.3
Inventories		172.5			158.5			183.9			159.7
Income tax receivable		8.2			8.3			16.7			12.9
Prepaid expenses and other current assets		35.3			16.9			21.1			20.5
Total current assets		658.4			629.0			636.5			664.4
Long-term assets:
Property, plant and equipment, net		189.6			197.0			224.6			220.3
Goodwill		231.0			233.0			220.7			301.9
Other intangible assets, net		196.7			207.7			264.7			256.7
Operating lease right-of-use assets, net		24.2			20.0			26.9			28.4
Deferred tax assets		35.4			36.8			33.0			33.6
Pre-production costs		27.0			27.2			44.5			36.1
Other long-term assets		32.0			38.4			34.0			37.7
Total long-term assets		735.9			760.1			848.4			914.7
Total assets	$	1,394.3		$	1,389.1		$	1,484.9		$	1,579.1

LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	124.5		$	108.5		$	133.5		$	138.7
Accrued employee liabilities		29.9			30.0			29.0			36.7
Other accrued liabilities		31.0			24.5			38.7			34.5
Short-term operating lease liabilities		6.3			6.0			6.6			6.8
Short-term debt		13.0			13.0			3.0			3.2
Income tax payable		8.3			6.6			7.5			8.1
Total current liabilities		213.0			188.6			218.3			228.0
Long-term liabilities:
Long-term debt		191.0			197.5			329.0			303.6
Long-term operating lease liabilities		19.0			14.8			20.9			21.8
Long-term income tax payable		16.7			22.1			9.3			16.7
Other long-term liabilities		15.4			14.0			16.5			14.3
Deferred tax liabilities		40.4			38.3			46.0			41.8
Total long-term liabilities		282.5			286.7			421.7			398.2
Total liabilities		495.5			475.3			640.0			626.2
Redeemable noncontrolling interest								—			11.1
Shareholders' equity:
Common stock, $0.50 par value, 100,000,000 shares authorized, 37,505,633 shares and 38,276,968 shares issued as of October 29, 2022 and April 30, 2022, respectively		18.7			19.2
Common stock, $0.50 par value, 100,000,000 shares authorized, 37,034,050 shares and 37,167,375 shares issued as of October 28, 2023 and April 29, 2023, respectively								18.5			18.6
Additional paid-in capital		174.7			169.0			183.8			181.0
Accumulated other comprehensive loss		(54.3	)		(26.8	)		(42.9	)		(19.0	)
Treasury stock, 1,346,624 shares as of October 29, 2022 and April 30, 2022		(11.5	)		(11.5	)
Treasury stock, 1,346,624 shares as of October 28, 2023 and April 29, 2023								(11.5	)		(11.5	)
Retained earnings		771.2			763.9			697.0			772.7
Total shareholders' equity		898.8			913.8			844.9			941.8
Total liabilities and shareholders' equity	$	1,394.3		$	1,389.1
Total liabilities, redeemable noncontrolling interest and shareholders' equity							$	1,484.9		$	1,579.1


	Three Months Ended October 29, 2022																				Three Months Ended October 28, 2023
	Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity			Redeemable noncontrolling interest			Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of July 30, 2022		38,001,714		$	19.0		$	172.0	$	(36.2	)	$	(11.5	)	$	768.1		$	911.4
Balance as of July 29, 2023																					$	0.9			37,356,156		$	18.7		$	182.5	$	(23.1	)	$	(11.5	)	$	764.8		$	931.4
Issuance of restricted stock, net of tax withholding		12,098			—			—		—			—			—			—			—			673			—			—		—			—			—			—
Purchase of redeemable noncontrolling interest																						(0.9	)		—			—			—		—			—			—			—
Purchases of common stock		(508,179	)		(0.3	)		—		—			—			(19.4	)		(19.7	)		—			(322,779	)		(0.2	)		—		—			—			(7.6	)		(7.8	)
Stock-based compensation expense		—			—			2.7		—			—			—			2.7			—			—			—			1.3		—			—			—			1.3
Other comprehensive loss		—			—			—		(18.1	)		—			—			(18.1	)		—			—			—			—		(19.8	)		—			—			(19.8	)
Net income		—			—			—		—			—			27.6			27.6
Net loss																						—			—			—			—		—			—			(55.3	)		(55.3	)
Dividends on common stock		—			—			—		—			—			(5.1	)		(5.1	)		—			—			—			—		—			—			(4.9	)		(4.9	)
Balance as of October 29, 2022		37,505,633		$	18.7		$	174.7	$	(54.3	)	$	(11.5	)	$	771.2		$	898.8
Balance as of October 28, 2023																					$	—			37,034,050		$	18.5		$	183.8	$	(42.9	)	$	(11.5	)	$	697.0		$	844.9

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited) (continued)


	Six Months Ended October 30, 2021																					Six Months Ended October 28, 2023
	Common stock shares			Common stock			Additional paid-in capital			Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity			Redeemable noncontrolling interest			Common stock shares			Common stock			Additional paid-in capital			Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of May 1, 2021		39,644,913		$	19.8		$	157.6		$	6.1		$	(11.5	)	$	746.0		$	918.0
Balance as of April 29, 2023																						$	11.1			37,167,375		$	18.6		$	181.0		$	(19.0	)	$	(11.5	)	$	772.7		$	941.8
Issuance of restricted stock, net of tax withholding		44,245			0.1			(0.1	)		—			—			(0.3	)		(0.3	)		—			189,454			0.1			(0.1	)		—			—			(3.8	)		(3.8	)
Exercise of stock options		13,000			—			0.5			—			—			—			0.5
Purchase of redeemable noncontrolling interest																							(11.1	)		—			—			—			—			—			—			—
Purchases of common stock		(965,029	)		(0.5	)		—			—			—			(41.9	)		(42.4	)		—			(322,779	)		(0.2	)		—			—			—			(7.6	)		(7.8	)
Stock-based compensation expense		—			—			5.8			—			—			—			5.8			—			—			—			2.9			—			—			—			2.9
Other comprehensive loss		—			—			—			(8.1	)		—			—			(8.1	)		—			—			—			—			(23.9	)		—			—			(23.9	)
Net income		—			—			—			—			—			56.6			56.6
Net loss																							—			—			—			—			—			—			(54.4	)		(54.4	)
Dividends on common stock		—			—			—			—			—			(10.6	)		(10.6	)		—			—			—			—			—			—			(9.9	)		(9.9	)
Balance as of October 30, 2021		38,737,129		$	19.4		$	163.8		$	(2.0	)	$	(11.5	)	$	749.8		$	919.5
Balance as of October 28, 2023																						$	—			37,034,050		$	18.5		$	183.8		$	(42.9	)	$	(11.5	)	$	697.0		$	844.9


	Six Months Ended						Six Months Ended
	October 29, 2022			October 30, 2021			October 28, 2023			October 29, 2022
Operating activities:
Net income	$	49.1		$	56.6
Net (loss) income							$	(54.4	)	$	49.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		24.5			25.9			28.4			24.5
Stock-based compensation expense		6.7			6.6			3.9			6.7
Change in cash surrender value of life insurance		(0.2	)		(0.6	)		(0.2	)		(0.2	)
Amortization of debt issuance costs		0.3			0.3			0.4			0.3
Loss (gain) on sale of property, plant and equipment		0.1			(0.4	)
Loss on sale of assets								0.5			0.1
Impairment of long-lived assets		0.4			—			0.6			0.4
Goodwill impairment								56.5			—
Change in deferred income taxes		1.0			0.1			(1.0	)		1.0
Other		0.2			0.1			0.8			0.2
Changes in operating assets and liabilities:
Accounts receivable		(50.6	)		(0.9	)		12.5			(50.6	)
Inventories		(19.5	)		(25.8	)		(29.1	)		(19.5	)
Prepaid expenses and other assets		(15.7	)		(10.5	)		(10.8	)		(15.7	)
Accounts payable		21.5			(1.3	)		(1.8	)		21.5
Other liabilities		10.3			(13.4	)		(12.5	)		10.3
Net cash provided by operating activities		28.1			36.7
Net cash (used in) provided by operating activities								(6.2	)		28.1

Investing activities:
Purchases of property, plant and equipment		(18.0	)		(21.3	)		(24.5	)		(18.0	)
Sale of property, plant and equipment		3.5			0.6
Proceeds from settlement of net investment hedge								0.6			—
Proceeds from disposition of assets								1.6			3.5
Net cash used in investing activities		(14.5	)		(20.7	)		(22.3	)		(14.5	)

Financing activities:
Taxes paid related to net share settlement of equity awards		(0.5	)		(0.3	)		(3.8	)		(0.5	)
Repayments of finance leases		(0.2	)		(0.3	)		(0.1	)		(0.2	)
Proceeds from exercise of stock options		—			0.5
Purchases of common stock		(31.6	)		(42.5	)		(7.8	)		(31.6	)
Cash dividends		(9.9	)		(10.3	)		(10.1	)		(9.9	)
Purchase of redeemable noncontrolling interest								(10.9	)		—
Proceeds from borrowings								213.9			—
Repayments of borrowings		(6.5	)		(16.8	)		(179.3	)		(6.5	)
Net cash used in financing activities		(48.7	)		(69.7	)
Net cash provided by (used in) financing activities								1.9			(48.7	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(7.3	)		(2.3	)		(7.9	)		(7.3	)
Decrease in cash and cash equivalents		(42.4	)		(56.0	)		(34.5	)		(42.4	)
Cash and cash equivalents at beginning of the period		172.0			233.2			157.0			172.0
Cash and cash equivalents at end of the period	$	129.6		$	177.2		$	122.5		$	129.6

Supplemental cash flow information:
Cash paid during the period for:
Interest	$	1.4		$	1.8		$	6.7		$	1.4
Income taxes, net of refunds	$	12.5		$	19.9		$	14.5		$	12.5
Operating lease obligations	$	4.0		$	4.5		$	4.5		$	4.0

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of business

Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer ~~appliance and medical devices.~~appliance.

~~Impact of the COVID-19 pandemic and supply chain disruptions~~

~~Various government programs have been enacted to provide assistance to businesses impacted by the COVID-19 pandemic. The amount of assistance the Company received was $0.2~~ ~~million and $2.1~~ ~~million in the three months ended October 29, 2022 and October 30, 2021, respectively. The Company received $4.3~~ ~~million and $4.0~~ ~~million in the six months ended October 29, 2022 and October 30, 2021, respectively. Government assistance has been reported as other income.~~

The Company continues to experience increased material and logistics costs, labor shortages, and most significantly, impacts from the worldwide semiconductor supply shortage. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in production schedules. The semiconductor supply shortage is also impacting the Company’s supply chain and its ability to meet demand at some of its non-automotive customers.

The Russia-Ukraine military conflict has negatively impacted the Company's European customers and suppliers. Although the Company does not have any operations in Russia or Ukraine, certain of its customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where the Company conducts business, including Europe and Asia. The economic sanctions imposed by the international community have further increased existing supply chain, logistics, and inflationary challenges.

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April ~~30, 2022,~~29, 2023, filed with the SEC on June ~~23, 2022.~~27, 2023. Results may vary from quarter to quarter for reasons other than seasonality.

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022 were both 13-week periods and the six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022 were both 26-week periods.

~~Table of Contents~~

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. ~~Actual~~These estimates and assumptions are subject to an inherent degree of uncertainty and may change, as new events occur, and additional information is obtained. As a result, actual results ~~could~~may differ from ~~these estimates.~~previously estimated amounts, and such differences may be material to the condensed consolidated financial statements.

Recently adopted accounting pronouncements

In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, “Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Accounting Standards Codification ("ASC") 606, as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. The Company adopted this ASU in the first quarter of fiscal 2024 on a prospective basis. The adoption of this ASU did not have a material impact on its condensed consolidated financial statements or related disclosures and is only applicable to future business acquisitions.

New accounting pronouncements not yet adopted

In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which requires public entities to disclose information about their reportable segments’ significant expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The adoption of this ASU will result in increased disclosures for the Company's segments.

Table of Contents

There have been no other newly issued or newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements. Further, at October 28, 2023, there are no other pronouncements pending adoption that are expected to have a material impact on the Company’s condensed consolidated financial statements.

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April ~~30, 2022.~~29, 2023. There have been no material changes to the significant accounting policies in the six months ended October ~~29, 2022.~~

~~New accounting pronouncements not yet adopted~~

~~In November 2021, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2021-10, “Government Assistance (Topic 832)~~,” which requires annual disclosures when an entity has received government assistance. This guidance is intended to improve the transparency of government assistance received by requiring disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on the registrant’s financial statements. The Company will adopt this standard effective April 29, 2023 and expects the standard to only impact annual financial statement footnote disclosures.28, 2023.

Note 2. Revenue

The Company generates revenue from ~~the~~ manufacturing of products for customers in diversified global markets. The substantial majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control ~~of the product~~ has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of ~~the~~such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts). and ongoing price adjustments. Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Contract balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022 were not material.

~~Table of Contents~~

Disaggregated revenue information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.


	Three Months Ended October 29, 2022										Three Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total		Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	97.8	$	40.1	$	14.0	$	1.1	$	153.0	$	70.9	$	52.0	$	11.7	$	1.5	$	136.1
Europe, the Middle East & Africa ("EMEA")		53.9		37.9		—		—		91.8		49.7		42.8		—		—		92.5
Asia		45.2		25.8		0.1		—		71.1		33.7		25.6		—		0.1		59.4
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0
Timing of revenue recognition:
Goods transferred at a point in time	$	192.3	$	103.8	$	14.1	$	1.1	$	311.3	$	149.9	$	120.4	$	11.7	$	1.6	$	283.6
Goods transferred over time		4.6		—		—		—		4.6		4.4		—		—		—		4.4
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0

Three Months Ended October 30, 2021

(in millions)

Automotive

Industrial

Interface

Medical

Total

Geographic net sales:

North America

$
99.3

$
42.1

$
17.8

$
0.8

$
160.0

EMEA

54.9

23.4

—

—

78.3

Asia

41.8

15.2

0.2

—

57.2

Total net sales

$
196.0

$
80.7

$
18.0

$
0.8

$
295.5

Timing of revenue recognition:

Goods transferred at a point in time

$
189.2

$
80.7

$
18.0

$
0.8

$
288.7

Goods transferred over time

6.8

—

—

—

6.8

Total net sales

$
196.0

$
80.7

$
18.0

$
0.8

$
295.5

Table of Contents


	Three Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	97.8	$	40.1	$	14.0	$	1.1	$	153.0
EMEA		53.9		37.9		—		—		91.8
Asia		45.2		25.8		0.1		—		71.1
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9
Timing of revenue recognition:
Goods transferred at a point in time	$	192.3	$	103.8	$	14.1	$	1.1	$	311.3
Goods transferred over time		4.6		—		—		—		4.6
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9


	Six Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	137.7	$	92.0	$	26.9	$	2.3	$	258.9
EMEA		101.9		93.9		—		—		195.8
Asia		73.0		49.9		—		0.1		123.0
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7
Timing of revenue recognition:
Goods transferred at a point in time	$	304.1	$	235.8	$	26.9	$	2.4	$	569.2
Goods transferred over time		8.5		—		—		—		8.5
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7


	Six Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	192.5	$	80.8	$	27.0	$	1.8	$	302.1
EMEA		106.0		66.4		—		—		172.4
Asia		75.0		48.7		0.1		—		123.8
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3
Timing of revenue recognition:
Goods transferred at a point in time	$	364.4	$	195.9	$	27.1	$	1.8	$	589.2
Goods transferred over time		9.1		—		—		—		9.1
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3

Six Months Ended October 30, 2021

(in millions)

Automotive

Industrial

Interface

Medical

Total

Geographic net sales:

North America

$
198.4

$
84.5

$
30.3

$
1.6

$
314.8

EMEA

112.7

43.2

—

—

155.9

Asia

80.7

31.5

0.4

—

112.6

Total net sales

$
391.8

$
159.2

$
30.7

$
1.6

$
583.3

Timing of revenue recognition:

Goods transferred at a point in time

$
378.9

$
159.2

$
30.7

$
1.6

$
570.4

Goods transferred over time

12.9

—

—

—

12.9

Total net sales

$
391.8

$
159.2

$
30.7

$
1.6

$
583.3

Note 3. Acquisition and Disposition

Acquisition

On April 20, 2023, the Company acquired 92.2% of the outstanding shares in Nordic Lights Group Corporation (“Nordic Lights”), a premium provider of high-quality lighting solutions for heavy duty equipment headquartered in Finland, for €121.8 million ($134.2 million) in cash. Between May 2023 and July 2023, the Company acquired an additional 7.2% of the outstanding shares of Nordic Lights for €9.2 million ($10.2 million), increasing the Company’s ownership to 99.4%. On October 10, 2023, the Company acquired the remaining 0.6% of the outstanding shares in Nordic Lights for €0.8 million ($0.9 million), as determined by the Finnish arbitral tribunal administering the redemption proceedings for the shares not tendered to the Company. Accordingly, the Company owned 100% of the outstanding shares in Nordic Lights as of October 10, 2023. The acquisition of Nordic Lights complements the Company’s existing LED lighting solution offerings.

Table of Contents

The acquisition was funded through a combination of borrowings under the Company's revolving credit facility and cash on hand. The results of the operations of Nordic Lights are reported within the Industrial segment from the date of acquisition. The acquisition was accounted for as a business combination. The Company has estimated the preliminary fair value of net assets acquired based on information currently available and will continue to adjust those estimates as additional information becomes available, including the refinement of valuation assumptions. As the Company finalizes the fair value of assets acquired and liabilities assumed, additional purchase price allocation adjustments will be recorded during the measurement period, but no later than one year from the date of the acquisition. The Company will reflect measurement period adjustments in the period in which the adjustments are determined. Measurement period adjustments recognized in the three months ended October 28, 2023, resulted from the receipt of incremental data utilized in the determination of fair value, including valuation assumptions.

The preliminary fair value and subsequent measurement period adjustments of the assets acquired and liabilities assumed, including a reconciliation to the total purchase price, were as follows:


	As reported as of July 29, 2023			Measurement period adjustments			As of October 28, 2023
(in millions)
Cash and cash equivalents	$	19.6		$	—		$	19.6
Accounts receivable		17.1			—			17.1
Inventories		9.6			(0.2	)		9.4
Property, plant and equipment		12.9			3.4			16.3
Identifiable intangible assets		68.1			24.5			92.6
Accounts payable		(10.8	)		—			(10.8	)
Long-term debt		(24.4	)		—			(24.4	)
Other assets and liabilities, net		(2.8	)		(0.5	)		(3.3	)
Deferred tax liabilities		(13.4	)		(5.4	)		(18.8	)
Total identifiable net assets acquired		75.9			21.8			97.7
Goodwill		69.6			(21.8	)		47.8
Total fair value of net assets acquired		145.5			—			145.5
Less: redeemable noncontrolling interest		(11.3	)		—			(11.3	)
Total purchase price	$	134.2		$	—		$	134.2

The noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the fair value of net assets acquired, as of the acquisition date. The noncontrolling interest is classified as a redeemable noncontrolling interest on the condensed consolidated balance sheets as minority shareholders owning less than 10% of the outstanding shares in a company in Finland have the right to require the company to redeem their shares. As noted above, in the six months ended October 28, 2023, the Company acquired the entire redeemable noncontrolling interest.

Goodwill arising from the acquisition was included in the Industrial segment as of October 28, 2023 and was attributable to potential synergies and an assembled workforce. The Company does not expect any recognized goodwill from this acquisition to be deductible for income tax purposes.

Intangible assets primarily include customer relationships, technology licenses and trademarks. The weighted average amortization period for the acquired intangible assets is approximately 18.2 years.

The pro-forma effects of this acquisition would not materially impact the Company’s operating results for the six months ended October 29, 2022, and as a result no pro-forma financial statements are presented. In the six months ended October 28, 2023, additional acquisition costs of $0.5 million were incurred and reported in selling and administrative expenses.

Disposition

In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of the Dabir business in the Medical segment. On October 13, 2023, the Company sold certain assets and contracts of its Dabir business to a third party for consideration of $1.5 million. In the three and six months ended October 28, 2023, the Company recorded a loss on the sale, including transaction costs, of $0.6 million, which was included in other income, net on the Company's condensed consolidated statement of operations. The discontinuation of the Dabir business does not qualify as a discontinued operation as it does not represent a strategic shift that would have a major effect on the Company's operations or financial results.

Table of Contents

Note 3.4. Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition, any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax (benefit) expense and effective tax rate for the three and six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022 were as follows:


	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
($ in millions)	October 29, 2022			October 30, 2021			October 29, 2022			October 30, 2021			October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Income before income taxes	$	33.4		$	33.0		$	59.3		$	67.8
Income tax expense	$	5.8		$	5.5		$	10.2		$	11.2
Pre-tax (loss) income													$	(55.5	)	$	33.4		$	(54.5	)	$	59.3
Income tax (benefit) expense													$	(0.2	)		5.8		$	(0.1	)		10.2
Effective tax rate		17.4	%		16.7	%		17.2	%		16.5	%		0.4	%		17.4	%		0.2	%		17.2	%

The effective tax rate for the three and six months ended October 28, 2023 was lower than the U.S. federal statutory tax rate of 21% primarily due to the impact of an impairment of goodwill which is non-deductible for tax purposes, income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, offset by global intangible low-tax income. The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. federal statutory tax rate of 21% primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. The effective tax rate for the three and six months ended October 30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

The Company’s gross unrecognized income tax benefits were $~~5.2~~4.6 million and $~~5.1~~4.5 million as of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, respectively. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, the lapsing of applicable statutes of limitations and changes in tax law. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.3 million and $0.2 million as of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, respectively.

~~On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted in the United States. The IR Act imposes a~~ 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. The Company is assessing the potential impact of the stock repurchase excise tax, but based on its preliminary assessment, the Company does not expect a material impact on its consolidated financial statements. Further, the remaining corporate tax changes included in the IR Act are not expected to have a material impact on the Company’s consolidated financial statements.

Note 4.5. Balance Sheet Components

Cash and cash equivalents

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, the Company had a balance of $~~33.3~~0.2 million and $~~40.0~~1.3 million, respectively, in money market accounts.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was $~~1.3~~1.5 million and $~~1.0~~1.3 million ~~as of~~at October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, respectively.

1112

Table of Contents

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:


(in millions)	October 29, 2022		April 30, 2022		October 28, 2023		April 29, 2023
Finished products	$	36.6	$	31.8	$	47.3	$	36.6
Work in process		15.0		12.9		17.7		14.4
Raw materials		120.9		113.8		118.9		108.7
Total inventories	$	172.5	$	158.5	$	183.9	$	159.7

Property, plant and equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:


(in millions)	October 29, 2022			April 30, 2022			October 28, 2023			April 29, 2023
Land	$	2.9		$	3.3		$	3.0		$	3.0
Buildings and building improvements		83.9			89.2			99.5			98.8
Machinery and equipment		397.0			407.5			411.4			414.3
Construction in progress		32.3			21.5			48.0			40.6
Total property, plant and equipment, gross		516.1			521.5			561.9			556.7
Less: accumulated depreciation		(326.5	)		(324.5	)		(337.3	)		(336.4	)
Property, plant and equipment, net	$	189.6		$	197.0		$	224.6		$	220.3

Depreciation expense was $~~7.5~~8.2 million and $~~8.5~~7.5 million in the three months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, respectively. Depreciation expense was $~~15.1~~16.5 million and $~~16.3~~15.1 million in the six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, respectively. As of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, capital expenditures recorded in accounts payable totaled $~~5.1~~5.6 million and $~~4.4~~4.5 million, respectively.

The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, the Company had $~~27.0~~44.5 million and $~~27.2~~36.1 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.

Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and amortized over the shorter of the life of the arrangement or the estimated useful life of the assets. As of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, Company-owned tooling was $~~13.1~~15.6 million and $~~14.6~~12.2 million, respectively.

The Company tests goodwill and indefinite-lived intangible assets for impairment on an annual basis as of the beginning of the fourth quarter each fiscal year. In addition, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim goodwill impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions.No

As a result of sustained decreases in the Company’s publicly quoted share price, market capitalization and lower than expected operating results, the Company concluded that a triggering event had occurred requiring an interim goodwill impairment assessment. These factors suggested that the fair value of one or more of the Company's reporting units may have fallen below their carrying amounts. The Company quantitatively assessed its reporting units which have performed substantially below the forecast used in its last quantitative fair value test. The reporting units that were quantitatively assessed were North American Automotive ("NAA") and European Automotive ("EA").

The Company engaged a third-party valuation specialist to assist management in performing the interim goodwill impairment assessment. The fair value of the NAA and EA reporting units were estimated using a combination of the income approach and market approach, weighted accordingly for the specific circumstances of the reporting unit. The income approach uses a discounted cash flow method and the market approach uses appropriate valuation multiples observed for the reporting unit’s guideline public companies. The determination of discounted cash flows are based on management’s estimates of revenue growth rates and earnings before interest, taxes, depreciation and amortization (“EBITDA”) margins, taking into consideration business and market conditions for the countries and markets in which the reporting unit operates. The Company calculates the discount rate based on a market-participant, risk-adjusted weighted average cost of capital, which considers industry specific rates of return on debt and equity capital for a target industry capital structure, adjusted for risks associated with business size, geography and other factors specific to the reporting unit. Long-range forecasting involves uncertainty which increases with each successive period. Revenue growth rates and profitability assumptions, especially in the outer years, involve a greater degree of uncertainty.

Based upon the results of the quantitative impairment test, the Company determined the carrying value of the NAA and EA reporting units exceeded their fair value at October 28, 2023. As a result, the Company recognized a non-cash goodwill impairment charge of $56.5 ~~impairment indicators were identified~~million ($50.4 million for NAA and $6.1 million for EA, respectively) in the three and six months ended October ~~29, 2022.~~28, 2023, which was determined as the excess carrying value over fair value of the respective reporting unit up to the carrying value of the goodwill immediately prior to the impairment. Any significant changes to the assumptions regarding future performance, an adverse change to macroeconomic conditions, a further reduction in the Company's market capitalization, or a change to other assumptions could result in impairment losses in the future, which could be significant.

12A summary of goodwill by reporting unit is as follows:

~~Table of Contents~~


(in millions)	October 28, 2023		April 29, 2023
Grakon Industrial	$	123.9	$	124.5
North American Automotive		49.4		99.8
Nordic Lights		45.8		69.6
European Automotive		—		6.4
Other		1.6		1.6
Total	$	220.7	$	301.9

Details of identifiable intangible assets are shown below:


	As of October 29, 2022									As of October 28, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average useful life (years)		Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	230.4	$	(61.0	)	$	169.4		14.2	$	303.6	$	(76.1	)	$	227.5		15.2
Trade names, patents and technology licenses		57.5		(32.0	)		25.5		5.8		74.0		(38.6	)		35.4		7.1
Total amortized intangible assets		287.9		(93.0	)		194.9				377.6		(114.7	)		262.9
Unamortized trade name		1.8		—			1.8				1.8		—			1.8
Total other intangible assets	$	289.7	$	(93.0	)	$	196.7			$	379.4	$	(114.7	)	$	264.7

As of April 30, 2022

(in millions)

Gross

Accumulated
amortization

Net

Weighted
average useful
life (years)

Amortized intangible assets:

Customer relationships and agreements

$
232.3

$
(55.1
)

$
177.2

14.7

Trade names, patents and technology licenses

58.0

(29.3
)

28.7

6.2

Total amortized intangible assets

290.3

(84.4
)

205.9

Unamortized trade name

1.8

—

1.8

Total other intangible assets

$
292.1

$
(84.4
)

$
207.7

Table of Contents


	As of April 29, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	286.7	$	(68.2	)	$	218.5		14.8
Trade names, patents and technology licenses		71.6		(35.2	)		36.4		6.0
Total amortized intangible assets		358.3		(103.4	)		254.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	360.1	$	(103.4	)	$	256.7

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:


(in millions)
Fiscal Year:
Remainder of 2023	$	9.3
2024		18.4
Remainder of 2024			$	11.8
2025		17.8		23.1
2026		16.9		22.2
2027		16.3		21.6
2028				19.3
Thereafter		116.2		164.9
Total	$	194.9	$	262.9

Note 6.7. Derivative Instruments and Hedging Activities

The Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.

For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in accumulated other comprehensive income (“AOCI”) in the condensed consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the condensed consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the condensed consolidated statements of income on the same line as the associated risk. For a designated net investment hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded as a cumulative translation adjustment in AOCI in the condensed consolidated balance sheets.

~~Table of Contents~~

Net investment hedges

The Company ~~has~~is exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries. To manage this risk, the Company designates certain qualifying derivative and non-derivative instruments, including cross-currency swaps and foreign currency-denominated debt, as net investment hedges of certain non-U.S. subsidiaries.

The Company had a variable-rate, cross-currency swap, ~~maturing on~~ ~~August 31, 2023~~, with a notional value of $60.0 million (€54.8 million)~~. The Company entered into the cross-currency swap to mitigate changes in net assets due to changes in U.S. dollar-euro spot exchange rates.~~, that matured on August 31, 2023 with a gain of approximately $0.6 million. The cross-currency swap iswas designated as a hedge of the Company’s net investment in ~~a euro-based subsidiary.~~its euro-denominated subsidiaries. The gain will remain in AOCI until the hedged net investment is sold or substantially liquidated.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For the three months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, the Company recorded gains of $~~0.6~~0.4 million and $~~0.1~~0.6 million, respectively, in interest expense, net in the condensed consolidated statements of income. For the six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, the Company recorded gains of $~~0.9~~1.1 million and $~~0.1~~0.9 million, respectively, in interest expense, net in the condensed consolidated statements of income.

Table of Contents

The Company has also designated its euro-denominated long-term borrowings of $290.6 million under the Credit Agreement as a hedge of the Company's investment in its euro-denominated subsidiaries. The objective of the designation is to protect the net investment in the foreign operation against adverse changes in the euro exchange rate. The change in the value of the euro-denominated long-term borrowings, which is due to changes in foreign exchange rates, is recorded as a cumulative translation adjustment in AOCI, net of tax. For the three months ended October 28, 2023, the transaction gain associated with this net investment hedge reported in AOCI was $7.5 million. For the six months ended October 28, 2023 the transaction gain associated with this net investment hedge reported in AOCI was $7.3 million.

Interest rate swaps

The Company ~~has~~utilizes interest rate swaps to limit its exposure to market fluctuations on its variable-rate borrowings. The interest rate swaps effectively convert a portion of the Company's variable rate borrowings to a fixed rate based upon a determined notional amount. The Company has an interest rate swap, maturing on October 31, 2027, with a notional value of $145.5 million (€132.0 million) and had two interest rate swaps that matured on August 31, 2023, with a notional value of $100.0 ~~million, to manage its exposure to, and to mitigate the impact of, interest rate variability.~~million. The interest rate swaps are designated as cash flow hedges.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI in the condensed consolidated balance sheets. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in the three or six months ended October 28, 2023 and October 29, ~~2022 or October 30, 2021.~~2022.

Derivatives not designated as hedges

The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities, in the condensed consolidated statements of income.

As of October ~~29, 2022~~28, 2023 and April ~~30, 2022,~~29, 2023, the Company held foreign currency forward contracts with a notional value of $~~62.6~~71.9 million and $~~38.6~~59.9 million, respectively. During the three and six months ended October 28, 2023, the Company recognized a loss of $0.8 million and $2.7 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income. During the three and six months ended October 29, 2022, the Company recognized a loss of $2.4 million and $2.8 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income. ~~During both the three and six months ended October 30, 2021, a gain of $0.3~~ ~~million was recognized in the condensed consolidated statements of income.~~

Fair value of derivative instruments on the balance sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:


		Asset/(Liability)							Asset/(Liability)
(in millions)	Financial Statement Caption	October 29, 2022			April 30, 2022			Financial Statement Caption	October 28, 2023			April 29, 2023
Derivatives designated as hedging instruments:
Net investment hedges	Prepaid expenses and other current assets	$	5.3		$	—
Net investment hedges	Other long-term assets	$	—		$	1.9		Other accrued liabilities	$	—		$	(0.5	)
Interest rate swaps	Prepaid expenses and other current assets	$	3.7		$	—		Prepaid expenses and other current assets	$	—		$	1.6
Interest rate swaps	Other long-term assets	$	—		$	3.0		Other long-term liabilities	$	(1.1	)	$	—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	0.1		$	—		Prepaid expenses and other current assets	$	—		$	0.1
Foreign currency forward contracts	Other accrued liabilities	$	(0.8	)	$	(0.2	)	Other accrued liabilities	$	(0.1	)	$	(0.1	)

Effect of derivative instruments on comprehensive income (loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:


	Three Months Ended				Six Months Ended				Three Months Ended					Six Months Ended
(in millions)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021		October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Net investment hedges	$	1.4	$	1.6	$	3.4	$	2.8	$	1.1		$	1.4	$	1.2		$	3.4
Interest rate swaps		0.7		0.7		0.7		0.6		(0.4	)		0.7		(2.7	)		0.7
Total									$	0.7		$	2.1	$	(1.5	)	$	4.1

Note 7.8. Debt

A summary of debt is shown below:


(in millions)	October 29, 2022			April 30, 2022			October 28, 2023			April 29, 2023
Term loan	$	200.0		$	206.3
Revolving credit facility							$	330.6		$	305.4
Other debt		4.6			5.1			4.4			4.7
Unamortized debt issuance costs		(0.6	)		(0.9	)		(3.0	)		(3.3	)
Total debt		204.0			210.5			332.0			306.8
Less: current maturities		(13.0	)		(13.0	)		(3.0	)		(3.2	)
Total long-term debt	$	191.0		$	197.5		$	329.0		$	303.6

Revolving credit facility/term loan

On October 31, 2022, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits the Company to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement ~~terminates~~matures on October 31, 2027.

Loans denominated in US dollars under the Credit Agreement bear interest at either (a) an adjusted base rate or (b) an adjusted term Secured Overnight Financing Rate (“SOFR”) rate or term SOFR daily floating rate (in each case, as determined in accordance with the provisions of the Credit Agreement) in each case plus an applicable ~~margin~~rate (the “Applicable ~~Margin”~~Rate”) ranging between 0.375% and 1.25%, in the case of adjusted base rate loans, and between 1.375% and 2.25%, in the case of adjusted term SOFR rate loans and term SOFR daily floating rate loans. Loans denominated in euros will bear interest at the Euro Interbank Offered Rate plus an Applicable Rate ranging between 1.375% and 2.25%. The Applicable ~~Margin~~Rate is set based on the Company’s consolidated leverage ratio.

~~In connection with~~As of October 28, 2023, the ~~Credit Agreement,~~outstanding balance under the ~~Company incurred debt issuance costs of approximately~~revolving credit facility included $~~3.2~~290.6 million ~~which will be capitalized and, along with~~(€275.0 million) of euro-denominated borrowings. The Company has designated the ~~current unamortized debt issuance costs of $0.6~~ ~~million, will be amortized into interest expense over the term~~euro-denominated borrowings as a net investment hedge of the ~~Credit Agreement.~~foreign currency exposure of its investments in euro-denominated subsidiaries. Refer to Note 7, "Derivative Financial Instruments and Hedging Activities" for further information.

The weighted-average interest rate on outstanding US dollar and euro-denominated borrowings under the ~~Prior~~ Credit Agreement was approximately ~~4.4~~7.2% and 5.6%, respectively, as of October ~~29, 2022.~~28, 2023. The ~~Prior~~ Credit Agreement ~~contained~~contains customary representations and warranties, financial covenants, restrictive covenants and events of default. As of October ~~29, 2022,~~28, 2023, the Company was in compliance with all the covenants in the ~~Prior~~ Credit Agreement.

Other debt

One of the Company’s European subsidiaries has debt that consists of three notes with maturities ranging from 2023 to 2031. The weighted-average interest rate on this debt was approximately 1.4% at October ~~29, 2022~~28, 2023 and $~~0.5~~3.0 million of the debt was classified as short-term.

Note 8.9. Shareholders’ Equity

Share buyback program

~~On March 31, 2021, the~~The Board of Directors authorized ~~the~~a program to purchase of up to $~~100.0~~200.0 million of the Company’s outstanding common stock through ~~March 31, 2023. On June 16, 2022, the Board of Directors authorized an increase in the share buyback program of an additional $100.0~~ ~~million, and extended the expiration of the program to~~ June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

Table of Contents

The following table summarizes the Company’s stock buyback activity under this share buyback program:


	Three Months Ended				Six Months Ended				Three Months Ended				Six Months Ended
(in millions, except share and per share data)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021		October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Shares purchased		508,179		807,516		825,814		965,029		322,779		508,179		322,779		825,814
Average price per share	$	38.69	$	43.07	$	38.21	$	43.93	$	24.03	$	38.69	$	24.03	$	38.21
Total cost	$	19.7	$	34.8	$	31.6	$	42.4	$	7.8	$	19.7	$	7.8	31.6

As of October ~~29, 2022,~~28, 2023, a total of ~~2,418,953~~3,113,154 shares have been purchased at a total cost of $~~102.8~~127.1 million since the commencement of the share buyback program. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of October ~~29, 2022,~~28, 2023, the dollar value of shares that remained available to be purchased by the Company under this share buyback program was $~~97.2~~72.9 million.

Dividends

The Company paid dividends totaling $~~4.9~~4.8 million and $~~5.1~~4.9 million in the three months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, respectively. The Company paid dividends totaling $~~9.9~~10.1 million and $~~10.3~~9.9 million in the six months ended October 28, 2023 and October 29, 2022, ~~and~~respectively. Dividends paid in the six months ended October ~~30, 2021, respectively.~~28, 2023 include $0.4 million of dividend equivalent payments for restricted stock units that vested at the end of fiscal 2023.

Accumulated other comprehensive income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in AOCI, net of tax is shown below:


	Three Months Ended October 29, 2022									Six Months Ended October 29, 2022									Three Months Ended October 28, 2023									Six Months Ended October 28, 2023
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(41.4	)	$	5.2		$	(36.2	)	$	(30.5	)	$	3.7		$	(26.8	)	$	(22.3	)	$	(0.8	)	$	(23.1	)	$	(19.8	)	$	0.8		$	(19.0	)
Other comprehensive income (loss)		(19.9	)		2.1			(17.8	)		(30.8	)		4.1			(26.7	)		(17.6	)		0.7			(16.9	)		(20.3	)		(1.5	)		(21.8	)
Tax (expense) benefit		0.2			(0.5	)		(0.3	)		0.2			(1.0	)		(0.8	)		(2.6	)		(0.3	)		(2.9	)		(2.4	)		0.3			(2.1	)
Net other comprehensive income (loss)		(19.7	)		1.6			(18.1	)		(30.6	)		3.1			(27.5	)		(20.2	)		0.4			(19.8	)		(22.7	)		(1.2	)		(23.9	)
Balance at the end of period	$	(61.1	)	$	6.8		$	(54.3	)	$	(61.1	)	$	6.8		$	(54.3	)	$	(42.5	)	$	(0.4	)	$	(42.9	)	$	(42.5	)	$	(0.4	)	$	(42.9	)

Three Months Ended October 30, 2021

Six Months Ended October 30, 2021

(in millions)

Currency translation adjustments

Derivative instruments

Total

Currency translation adjustments

Derivative instruments

Total

Balance at beginning of period

$
7.4

$
(4.5
)

$
2.9

$
11.5

$
(5.4
)

$
6.1

Other comprehensive income (loss)

(6.7
)

2.3

(4.4
)

(10.6
)

3.4

(7.2
)
Tax (expense) benefit

0.1

(0.6
)

(0.5
)

(0.1
)

(0.8
)

(0.9
)
Net other comprehensive income (loss)

(6.6
)

1.7

(4.9
)

(10.7
)

2.6

(8.1
)
Balance at the end of period

$
0.8

$
(2.8
)

$
(2.0
)

$
0.8

$
(2.8
)

$
(2.0
)

~~Table of Contents~~


	Three Months Ended October 29, 2022									Six Months Ended October 29, 2022
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(41.4	)	$	5.2		$	(36.2	)	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(19.9	)		2.1			(17.8	)		(30.8	)		4.1			(26.7	)
Tax (expense) benefit		0.2			(0.5	)		(0.3	)		0.2			(1.0	)		(0.8	)
Net other comprehensive income (loss)		(19.7	)		1.6			(18.1	)		(30.6	)		3.1			(27.5	)
Balance at the end of period	$	(61.1	)	$	6.8		$	(54.3	)	$	(61.1	)	$	6.8		$	(54.3	)

~~On September 14, 2022, the Company's stockholders approved~~The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (“2022 Plan”)~~. After that date, no further awards can be granted under~~, the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company’s stockholders approved the 2022 Plan ~~provides for discretionary~~on September 14, 2022. The Company can no longer make grants ~~of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units~~under the 2014 Plan, 2010 Plan and ~~performance grants to employees and directors.~~2004 Plan.

Subject to adjustment as provided in the 2022 Plan and the 2022 Plan’s share counting provisions, the number of shares of the Company's common stock that will be available for all awards under the 2022 Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of October ~~29, 2022,~~28, 2023, there were ~~5,244,232~~4,943,780 shares available for award under the 2022 Plan.

The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the 2022 Plan, the 2014 Plan, the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), the Methode Electronics, Inc. 2007 Stock Plan (“2007 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company can no longer make grants under the 2014 Plan, 2010 Plan, 2007 Plan and 2004 Plan.18

As of October ~~29, 2022,~~28, 2023, the Company had ~~949,674~~933,674 RSAs outstanding which may be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, up to an additional ~~474,837~~466,837 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with ~~Accounting Standards Codification~~ASC 718, based on projections of the Company’s current business portfolio, no compensation expense has been recognized for the RSAs or PUs to date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense at target level of performance is $~~27.3~~26.8 million as of October ~~29, 2022,~~28, 2023, which, subject to the performance conditions being met, will be recognized through fiscal 2025.

The following table summarizes RSA activity:

Restricted
stock
awards

Weighted
average grant
date fair value

Non-vested at April 30, 2022

928,412

$
28.50

Awarded

21,262

$
38.41

Vested

—

$
—

Forfeited

—

$
—

Non-vested at October 29, 2022

949,674

$
28.72

~~Table of Contents~~


	Restricted stock awards		Weighted average grant date fair value
Non-vested at April 29, 2023		933,674	$	28.73
Awarded		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Non-vested at October 28, 2023		933,674	$	28.73

Restricted stock units

RSUs granted vest over a pre-determined period of time, up to five years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest.

The following table summarizes RSU activity:


	Restricted stock units			Weighted average grant date fair value		Restricted stock units			Weighted average grant date fair value
Non-vested at April 30, 2022		936,391		$	29.16
Non-vested at April 29, 2023							727,467		$	30.60
Awarded		73,292		$	39.10		207,050		$	22.83
Vested		—		$	—		(866	)	$	38.24
Forfeited		(734	)	$	48.41		(13,474	)	$	41.62
Non-vested at October 29, 2022		1,008,949		$	29.87
Non-vested at October 28, 2023							920,177		$	28.68

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of October ~~29, 2022,~~28, 2023, common stock to be delivered to these executives totaled 577,055 shares.

Table of Contents

Director awards

The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. ~~In the six months ended October 29, 2022, the Company~~The following table summarizes awards granted to non-employee directors:~~43,043~~ ~~shares, of which~~ ~~27,503~~ shares were deferred. All dividends on deferred shares are reinvested into additional deferred shares based on the closing price of the Company’s common stock on the dividend payment date. Deferred shares will be settled with shares of common stock upon each director’s retirement from the Company’s Board of Directors. As of October 29, 2022, there were ~~45,459~~ ~~deferred shares outstanding.~~


	Non-employee director awards			Deferred non-employee director awards		Total			Weighted average grant date fair value
Outstanding at April 29, 2023		—			45,750		45,750		$	40.56
Awarded		16,804			30,194		46,998		$	33.22
Issued		(16,804	)		—		(16,804	)	$	33.32
Outstanding at October 28, 2023		—			75,944		75,944		$	37.62

Stock options

The following table summarizes stock option activity:


	Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)		Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 30, 2022		60,000	$	37.01		2.2	$	0.5
Outstanding and exercisable at April 29, 2023										20,000	$	37.01		1.2	$	0.1
Exercised		—	$	—						—	$	—
Forfeited		—	$	—						—	$	—
Outstanding and exercisable at October 29, 2022		60,000	$	37.01		1.7	$	0.2
Outstanding and exercisable at October 28, 2023										20,000	$	37.01		0.7	$	0.0

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.

Stock-based compensation expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:


	Three Months Ended				Six Months Ended				Three Months Ended				Six Months Ended
(in millions)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021		October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
RSUs	$	2.7	$	2.6	$	5.1	$	5.1	$	1.3	$	2.7	$	2.3	$	5.1
Deferred director awards		—		—		1.0		0.8
Director awards		—		—		0.6		0.7
Deferred non-employee director awards										—		—		1.0		1.0
Non-employee director awards										—		—		0.6		0.6
Total stock-based compensation expense	$	2.7	$	2.6	$	6.7	$	6.6	$	1.3	$	2.7	$	3.9	$	6.7

~~Table of Contents~~

Note 9.10. (Loss) Income per Share

Basic (loss) income per share attributable to Methode is calculated by dividing net (loss) income attributable to Methode by the weighted average number of common shares outstanding for the applicable period, but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted (loss) income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

Table of Contents

The following table sets forth the computation of basic and diluted (loss) income per ~~share:~~share attributable to Methode:

Three Months Ended

Six Months Ended

October 29, 2022

October 30, 2021

October 29, 2022

October 30, 2021

Numerator:

Net income (in millions)

$
27.6

$
27.5

$
49.1

$
56.6

Denominator:

Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units

36,126,132

37,544,357

36,346,054

37,741,923

Dilutive potential common shares

715,699

538,899

682,762

528,684

Denominator for diluted income per share

36,841,831

38,083,256

37,028,816

38,270,607

Basic and diluted income per share:

Basic income per share

$
0.76

$
0.73

$
1.35

$
1.50

Diluted income per share

$
0.75

$
0.72

$
1.33

$
1.48

Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding

940,510

928,412

934,522

928,412


	Three Months Ended					Six Months Ended
	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Numerator:
Net (loss) income attributable to Methode (in millions)	$	(55.3	)	$	27.6	$	(54.4	)	$	49.1

Denominator:
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units		35,671,677			36,126,132		35,679,776			36,346,054
Dilutive potential common shares		—			715,699		—			682,762
Denominator for diluted income per share		35,671,677			36,841,831		35,679,776			37,028,816

(Loss) income per share attributable to Methode:
Basic	$	(1.55	)	$	0.76	$	(1.52	)	$	1.35
Diluted	$	(1.55	)	$	0.75	$	(1.52	)	$	1.33

Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding		1,543,183			940,510		1,536,206			934,522

In the three and six months ended October 28, 2023, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 584,000 and 589,000 common shares for the three and six months ended October 28, 2023, respectively.

Note ~~10.~~11. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer. The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode ~~has~~ developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures. In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of Dabir Surfaces. In October 2023, the Company sold certain assets of its Dabir Surfaces business. See Note 3, "Acquisition and Disposition" for more information.

1921

Table of Contents

The tables below present information about the Company’s reportable segments:


	Three Months Ended October 29, 2022																	Three Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated			Automotive			Industrial			Interface		Medical				Eliminations/ Corporate			Consolidated
Net sales	$	198.3		$	107.8		$	14.1	$	1.1		$	(5.4	)	$	315.9		$	158.0		$	128.0		$	11.7	$	1.6			$	(11.3	)	$	288.0
Transfers between segments		(1.4	)		(4.0	)		—		—			5.4			—			(3.7	)		(7.6	)		—		—				11.3			—
Net sales to unaffiliated customers	$	196.9		$	103.8		$	14.1	$	1.1		$	—		$	315.9		$	154.3		$	120.4		$	11.7	$	1.6		��	$	—		$	288.0

Income (loss) from operations	$	23.4		$	25.0		$	1.6	$	(1.4	)	$	(15.8	)	$	32.8		$	(61.5	)	$	25.7		$	1.0	$	(0.7	)		$	(15.8	)	$	(51.3	)
Interest expense, net																0.5																		4.4
Other income, net																(1.1	)																	(0.2	)
Income before income taxes															$	33.4
Pre-tax loss																																	$	(55.5	)

Goodwill impairment																		$	56.5		$	—		$	—	$	—			$	—		$	56.5


	Three Months Ended October 30, 2021																	Three Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated			Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	197.1		$	82.7		$	18.0	$	0.8		$	(3.1	)	$	295.5		$	198.3		$	107.8		$	14.1	$	1.1		$	(5.4	)	$	315.9
Transfers between segments		(1.1	)		(2.0	)		—		—			3.1			—			(1.4	)		(4.0	)		—		—			5.4			—
Net sales to unaffiliated customers	$	196.0		$	80.7		$	18.0	$	0.8		$	—		$	295.5		$	196.9		$	103.8		$	14.1	$	1.1		$	—		$	315.9

Income (loss) from operations	$	23.6		$	18.8		$	4.4	$	(1.8	)	$	(11.8	)	$	33.2		$	23.4		$	25.0		$	1.6	$	(1.4	)	$	(15.8	)	$	32.8
Interest expense, net																1.1																	0.5
Other income, net																(0.9	)																(1.1	)
Income before income taxes															$	33.0
Pre-tax income																																$	33.4


	Six Months Ended October 29, 2022																	Six Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated			Automotive			Industrial			Interface			Medical			Eliminations/ Corporate			Consolidated
Net sales	$	375.6		$	201.5		$	27.1	$	1.8		$	(7.7	)	$	598.3		$	319.1		$	250.6		$	27.0		$	2.4		$	(21.4	)	$	577.7
Transfers between segments		(2.1	)		(5.6	)		—		—			7.7			—			(6.5	)		(14.8	)		(0.1	)		—			21.4			—
Net sales to unaffiliated customers	$	373.5		$	195.9		$	27.1	$	1.8		$	—		$	598.3		$	312.6		$	235.8		$	26.9		$	2.4		$	—		$	577.7

Income (loss) from operations	$	38.1		$	47.4		$	3.2	$	(2.9	)	$	(31.2	)	$	54.6		$	(64.3	)	$	49.9		$	3.9		$	(2.9	)	$	(34.1	)	$	(47.5	)
Interest expense, net																0.5																		7.2
Other income, net																(5.2	)																	(0.2	)
Income before income taxes															$	59.3
Pre-tax loss																																	$	(54.5	)

Goodwill impairment																		$	56.5		$	—		$	—		$	—		$	—		$	56.5


	Six Months Ended October 30, 2021																	Six Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated			Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	394.1		$	163.9		$	30.7	$	1.6		$	(7.0	)	$	583.3		$	375.6		$	201.5		$	27.1	$	1.8		$	(7.7	)	$	598.3
Transfers between segments		(2.3	)		(4.7	)		—		—			7.0			—			(2.1	)		(5.6	)		—		—			7.7			—
Net sales to unaffiliated customers	$	391.8		$	159.2		$	30.7	$	1.6		$	—		$	583.3		$	373.5		$	195.9		$	27.1	$	1.8		$	—		$	598.3

Income (loss) from operations	$	50.9		$	39.0		$	5.5	$	(3.0	)	$	(25.1	)	$	67.3		$	38.1		$	47.4		$	3.2	$	(2.9	)	$	(31.2	)	$	54.6
Interest expense, net																2.2																	0.5
Other income, net																(2.7	)																(5.2	)
Income before income taxes															$	67.8
Pre-tax income																																$	59.3

(in millions)

October 29, 2022

April 30, 2022

Identifiable assets:

Automotive

$
700.6

$
689.8

Industrial

463.7

455.3

Interface

113.2

108.1

Medical

6.5

7.9

Eliminations/Corporate

110.3

128.0

Total identifiable assets

$
1,394.3

$
1,389.1

2022

Table of Contents


(in millions)	October 28, 2023		April 29, 2023
Identifiable assets:
Automotive	$	643.3	$	700.2
Industrial		636.8		672.3
Interface		117.5		127.2
Medical		0.8		6.2
Eliminations/Corporate		86.5		73.2
Total identifiable assets	$	1,484.9	$	1,579.1

Note ~~11.~~12. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Companyterminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. The Company opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal ~~currently is being briefed. No hearing date has yet been set.~~ and the proper course of further proceedings. That briefing was thereafter submitted.

Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.

Note 14. Subsequent Events

On December 5, 2023, the Board of Directors of the Company removed Joseph Khoury from his position as Chief Operating Officer of the Company, and Mr. Khoury was terminated as an employee of the Company’s Egyptian subsidiary and is no longer associated with the Company. Mr. Khoury was placed on leave from that position on July 10, 2023, as previously reported in the Company’s Current Report on Form 8-K filed on July 14, 2023. As previously disclosed, multiple other officers of the Company have assumed Mr. Khoury’s management duties during this period, while remaining in their current positions and as a result, the Company has eliminated the position of Chief Operating Officer for the present time following Mr. Khoury’s departure from Methode. As a result, the Company expects to reverse between $3.5 million and $3.9 million of previously recognized compensation expense in the third quarter of fiscal 2024.

On December 6, 2023, the Board of Directors of the Company declared a quarterly dividend of $0.14 per share to be paid on January 26, 2024, to common stockholders of record at the close of business on January 12, 2024.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used herein, “we,” “us,” “our,” the “Company” or “Methode” means Methode Electronics, Inc. and its subsidiaries.

This Quarterly Report on Form 10-Q (“Quarterly Report”) includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect, when made, our current views with respect to current events and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to our operations and business environment, which may cause our actual results to be materially different from any future results, express or implied, by such forward-looking statements. All statements that address future operating, financial or business performance or our strategies or expectations are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following:

Additional details and factors are discussed under the caption “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended April ~~30, 2022.~~29, 2023. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. Any forward-looking statements made by us speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

We are a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. We design, engineer and produce mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing our broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

Our solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer ~~appliance and medical devices.~~appliance. Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

The COVID-19 pandemic and the ongoing measures to reduce its spread have negatively impacted the global economy, disrupted consumer and customer demand and global supply chains, and resulted in manufacturing inefficiencies and increased freight costs due to global capacity constraints. Beginning late in the fourth quarter of fiscal 2022 and continuing intoIn the first quarter of fiscal ~~2023, various regions in China, including regions where~~2024, we ~~and our customers have operations, were subjected~~made the decision to ~~lock-downs imposed by governmental authorities to mitigate~~initiate the ~~spread~~discontinuation of ~~COVID-19 in those areas. The resulting industry-wide production interruptions adversely impacted our results of operations~~the Dabir business in the ~~six months ended~~Medical segment. In October ~~29, 2022.~~2023, we sold certain assets of the Dabir business, and no longer operate this business. For further information, see Note 3, “Acquisition and Disposition” to the condensed consolidated financial statements included in this Report.

~~Any future resurgence~~Impacts of ~~COVID-19,~~Macroeconomic and ~~its related impacts,~~Geopolitical Conditions

Adverse macroeconomic conditions, including but not limited to inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, wage and commodity inflation, currency fluctuations and new or increased tariffs, could ~~negatively impact~~adversely affect demand for our ~~business~~products. We continue to monitor the Russia-Ukraine war and ~~future results of operations. The extent of~~ the ~~impact will depend on a number of evolving~~associated sanctions and ~~uncertain factors, including~~other restrictions. We also are monitoring the ~~duration and spread of COVID-19 (and its variants), the rate of vaccinations, actions taken by governmental authorities to further restrict business~~Israel-Hamas war. Although we have no operations ~~and social activity and impose travel restrictions, shifting consumer demand, the ability of our supply chain to deliver~~ in ~~a timely and cost-effective manner, the ability of our employees and manufacturing facilities to operate efficiently and effectively, the continued viability and financial stability~~Russia, Ukraine or Israel, certain of our customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where we do business, including EMEA and Asia. The economic sanctions imposed on Russia have further increased existing global supply chain, logistics, and inflationary challenges. The full impact of the conflicts on our business operations and financial performance remains uncertain and will depend on future ~~access to capital.~~developments, including the severity and duration of the conflicts and their impact on regional and global economic conditions. We will continue to ~~focus~~monitor the conflicts and assess the related restrictions and other effects on ~~effectively managing the unprecedented challenges~~our employees, customers, and ~~uncertainties of the pandemic on a global basis.~~business.

WeDue to various factors that are beyond our control, there continues to be global supply chain disruptions, including a worldwide semiconductor supply shortage. In addition, we have experienced, and may continue to experience, business interruptions, including customer shutdowns and increased material and logistics costs and labor ~~shortages, and most significantly, impacts from the worldwide semiconductor supply shortage.~~shortages. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in their production schedules. The semiconductor supply shortage is also impacting our supply chain and our ability to meet demand at some of our non-automotive customers. We expect this semiconductor shortage to have a continued impact on our operating results and financial condition ~~for the remainder of~~in fiscal ~~2023.~~2024.

We acquired 92.2% of the outstanding shares of Nordic Lights on April 20, 2023. We acquired the remaining 7.8% of the outstanding shares of Nordic Lights in the six months ended October 28, 2023. Accordingly, as of October 28, 2023, we own 100% of Nordic Lights. The results of operations of Nordic Lights are reported within the Industrial segment. For further information, see Note 3, “Acquisition and ~~Geopolitical Conditions~~Disposition” to the condensed consolidated financial statements included in this Report.

Adverse macroeconomic conditions, including but not limited to inflation, slower growth or recession, new or increased tariffs, changes to fiscal and monetary policy, higher interest rates, wage and commodity inflation and currency fluctuations could adversely affect demand for our products. In addition, the Russia/Ukraine conflict has resulted in, among other things, economic sanctions imposed by the international community which have impacted the global economy and given rise to potential global security issues that may adversely affect international business and economic conditions. Although we have no operations in Russia or Ukraine, certain of our customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where we do business, including Europe and Asia. The economic sanctions imposed on Russia have further increased existing global supply chain, logistics, and inflationary challenges. For example, in response to the sanctions imposed on Russia by Western countries, Russia has reduced the volume of natural gas it sends to European countries, which has resulted in, and could continue to result in increased energy costs for our EMEA operations. If Russia further reduces or turns off energy supplies to Europe, our EMEA operations could be adversely affected.

The table below compares our results of operations between the three and six months ended October ~~29, 2022~~28, 2023 and the three and six months ended October ~~30, 2021:~~29, 2022:

Net sales ~~increased $20.4~~decreased $27.9 million, or ~~6.9%~~8.8%, to $288.0 million in the three months ended October 28, 2023, compared to $315.9 million in the three months ended October 29, ~~2022, compared to $295.5 million in the three months ended October 30, 2021.~~2022. The ~~increase~~decrease was primarily due to ~~higher~~lower sales volumes in the ~~Industrial~~Automotive segment, partially offset by ~~lower~~the acquisition of Nordic Lights, which contributed $20.9 million of net sales into the ~~Interface segment. Net sales were unfavorably impacted by~~Industrial segment, and favorable foreign currency translation of ~~$22.2 million, primarily due to the strengthening of the U.S. dollar relative to the euro and Chinese renminbi.~~$3.5 million. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $0.6 million in the three months ended October 28, 2023, compared to $5.8 million in the three months ended October 29, ~~2022, compared to $4.4 million in the three months ended October 30, 2021.~~2022. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales ~~increased $41.2~~decreased $47.1 million, or ~~14.2%~~15.2%.

Net sales ~~increased $15.0~~decreased $20.6 million, or ~~2.6%~~3.4%, to $577.7 million in the six months ended October 28, 2023, compared to $598.3 million in the six months ended October 29, ~~2022, compared to $583.3 million in the six months ended October 30, 2021.~~2022. The ~~increase~~decrease was primarily due to ~~higher~~lower sales volumes in the ~~Industrial~~Automotive segment, partially offset by ~~lower~~the acquisition of Nordic Lights, which contributed $42.1 million of net sales into the ~~Automotive segment. Net sales were unfavorably impacted by~~Industrial segment, and favorable foreign currency translation of ~~$36.5 million, primarily due to the strengthening of the U.S. dollar relative to the euro and Chinese renminbi.~~$4.0 million. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $1.3 million in the six months ended October 28, 2023, compared to $16.9 million in the six months ended October 29, ~~2022, compared to $4.5 million in the six months ended October 30, 2021.~~2022. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales ~~increased $39.1~~decreased $51.1 million, or ~~6.8%~~8.8%.

Cost of products sold ~~increased $15.5~~decreased $6.1 million, or ~~6.8%~~2.5%, to $235.7 million (81.8% of net sales) in the three months ended October 28, 2023, compared to $241.8 million (76.5% of net sales) in the three months ended October 29, ~~2022, compared~~2022. Excluding the acquisition of Nordic Lights, which accounted for $14.9 million, and foreign currency translation of $2.5 million, cost of products sold decreased $23.5 million. The decrease was primarily due to ~~$226.3~~lower material costs as a result of a decrease in sales volumes, partially offset by higher salary, freight and operating expenses. Restructuring costs were $0.2 million ~~(76.6% of net sales)~~ in the three months ended October ~~30, 2021. Excluding foreign currency translation, cost of products sold increased $32.2 million. The increase was primarily due~~28, 2023, compared to ~~higher material costs of $29.5~~$0.1 million ~~as a result of an increase~~ in ~~sales volumes and costs related to spot buys of materials.~~the three months ended October 29, 2022.

Cost of products sold increased ~~$20.0~~$9.0 million, or ~~4.5%~~1.9%, to $471.4 million (81.6% of net sales) in the six months ended October 28, 2023, compared to $462.4 million (77.3% of net sales) in the six months ended October 29, ~~2022, compared~~2022. Excluding the acquisition of Nordic Lights, which accounted for $30.8 million, and foreign currency translation of $2.9 million, cost of products sold decreased $24.7 million. The decrease was primarily due to ~~$442.4~~lower material costs as a result of a decrease in sales volumes, partially offset by higher salary, freight and operating expenses. Restructuring costs were $0.8 million ~~(75.8% of net sales)~~ in the six months ended October ~~30, 2021. Excluding foreign currency translation, cost~~28, 2023, compared to $0.1 million in the six months ended October 29, 2022.

Gross profit margin was 18.2% of net sales in the three months ended October 28, 2023, compared to 23.5% of net sales in the three months ended October 29, ~~2022, compared to 23.4%~~2022. The decrease in gross profit margin was primarily a result of lower sales and operational inefficiencies in the Automotive segment. The operational inefficiencies were caused mainly by higher labor costs and premium freight.

Gross profit margin was 18.4% of net sales in the ~~three~~six months ended October ~~30, 2021. Gross margins remained steady as higher sales volumes offset higher material costs.~~

~~Gross profit margin was~~28, 2023, compared to 22.7% of net sales in the six months ended October 29, ~~2022, compared to 24.2%~~2022. The decrease in gross profit margin was primarily a result of ~~net~~lower sales and operational inefficiencies in the ~~six months ended October 30, 2021.~~Automotive segment. The ~~decrease was due~~operational inefficiencies were caused mainly by labor and vendor issues which led to ~~higher material~~planning deficiencies, inventory shortages, unrecoverable spot purchases and ~~other costs associated with supply chain disruptions, partially offset by higher sales volumes.~~premium freight, and delayed shipments.

Selling and administrative expenses increased ~~$5.4~~$4.3 million, or ~~17.3%~~11.7%, to $40.9 million (14.2% of net sales) in the three months ended October 28, 2023, compared to $36.6 million (11.6% of net sales) in the three months ended October 29, ~~2022, compared to $31.2~~2022. The acquisition of Nordic Lights and foreign currency translation accounted for $2.6 million ~~(10.6%~~and $1.0 million, respectively, of ~~net sales) in~~ the ~~three months ended October 30, 2021.~~increase. Excluding Nordic Lights and foreign currency translation, selling and administrative expenses increased ~~$7.0 million. The increase was~~$0.7 million primarily due to higher ~~annual cash incentive compensation expense,~~ professional fees, partially offset by lower incentive and ~~salary~~stock-based compensation expense. Restructuring costs were $0.4 million in both the three months ended October 28, 2023 and the three months ended October 29, 2022.

Selling and administrative expenses increased ~~$7.9~~$13.5 million, or ~~12.3%~~18.8%, to $85.4 million (14.8% of net sales) in the six months ended October 28, 2023, compared to $71.9 million (12.0% of net sales) in the six months ended October 29, ~~2022, compared to $64.0~~2022. The acquisition of Nordic Lights and foreign currency translation accounted for $4.6 million ~~(11.0%~~and $1.6 million, respectively, of ~~net sales) in~~ the ~~six months ended October 30, 2021.~~increase. Excluding Nordic Lights and foreign currency translation, selling and administrative expenses increased ~~$10.7~~$7.3 million. The increase was primarily due to higher ~~annual cash incentive compensation~~professional fees, outbound freight expense and salary expense, ~~professional fees~~partially offset by lower incentive and ~~travel~~stock-based compensation expense. Restructuring costs were $0.5 million in both the six months ended October 28, 2023 and the six months ended October 29, 2022.

In the three and six months ended October 28, 2023, we recognized a goodwill impairment of $56.5 million in the Automotive segment. For further information, see Note 6, "Goodwill and Other Intangible Assets" to the condensed consolidated financial statements included in this Report.

Amortization of intangibles was $6.2 million in the three months ended October 28, 2023, compared to $4.7 million in the three months ended October 29, ~~2022, compared to $4.8~~2022. Amortization of intangibles was $11.9 million in the ~~three~~six months ended October ~~30, 2021.~~

~~Amortization of intangibles was~~28, 2023, compared to $9.4 million in the six months ended October 29, ~~2022, compared~~2022. The increase in both periods was due to ~~$9.6 million in~~ the ~~six months ended October 30, 2021.~~recognition of amortization expense associated with the acquisition of Nordic Lights.

Interest expense, net was $4.4 million in the three months ended October 28, 2023, compared to $0.5 million in the three months ended October 29, ~~2022,~~2022. Interest expense, net was $7.2 million in the six months ended October 28, 2023, compared to $0.5 million in the six months ended October 29, 2022. The increase in both periods was due to higher level of borrowings and increasing interest rates.

Other income, net was $0.2 million in the three months ended October 28, 2023, compared to $1.1 million in the three months ended October ~~30, 2021. The decrease~~29, 2022. Net foreign exchange gain was due to higher interest income of $0.8 million, partially offset by higher interest expense of $0.2 million recognized during the period. Higher interest income and interest expense was due to increasing interest rates.

Interest expense, net was $0.5 million in the six months ended October 29, 2022, compared to $2.2 million in the six months ended October 30, 2021. The decrease was due to higher interest income of $1.5 million primarily from our cash holdings as a result of increasing interest rates.

~~Other income, net was $1.1~~$0.3 million in the three months ended October ~~29, 2022,~~28, 2023, compared to $0.9 million in the three months ended October ~~30, 2021. Net foreign exchange gain was $0.9 million in the three months ended October~~ 29, ~~2022, compared to a net foreign exchange loss of $1.2 million in the three months ended October 30, 2021.~~2022. In the three months ended October ~~29, 2022,~~28, 2023, we ~~received $0.2~~recognized a $0.6 million loss on the sale of ~~international government assistance, compared to $2.1 million in the three months ended October 30, 2021.~~certain assets of Dabir.

Other income, net was $0.2 million in the six months ended October 28, 2023, compared to $5.2 million in the six months ended October 29, ~~2022, compared to $2.7~~2022. Net foreign exchange gain was $0.5 million in the six months ended October ~~30, 2021. Net foreign exchange gain was~~28, 2023, compared to $0.9 million in the six months ended October 29, ~~2022,~~2022. In the six months ended October 28, 2023, we received $0.1 million of international government assistance, compared to ~~a net foreign exchange loss of $1.5~~$4.3 million in the six months ended October ~~30, 2021.~~29, 2022. In the six months ended October ~~29, 2022,~~28, 2023, we ~~received $4.3~~recognized a $0.6 million loss on the sale of ~~international government assistance with respect to the COVID-19 pandemic, compared to $4.0 million in the six months ended October 30, 2021.~~certain assets of Dabir.

Income tax benefit was $0.2 million (0.4% effective tax rate) in the three months ended October 28, 2023, compared to income tax expense ~~was~~of $5.8 million (17.4% effective tax rate) in the three months ended October 29, ~~2022, compared to $5.5~~2022. Income tax benefit was $0.1 million ~~(16.7%~~(0.2% effective tax rate) in the ~~three~~six months ended October ~~30, 2021.~~ 28, 2023, compared to income tax expense of $10.2 million (17.2% effective tax rate) in the six months ended October 29, 2022.

The effective tax rate for the three and six months ended October 28, 2023 was lower than the U.S. federal statutory tax rate of 21% primarily due to the impact of an impairment of goodwill which is non-deductible for tax purposes, income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions offset by global intangible low-tax income. The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. federal statutory tax rate of 21% primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. ~~The effective tax rate for~~

Net loss was $55.3 million in the three months ended October ~~30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.~~

~~Income tax expense was $10.2 million (17.2% effective tax rate) in the six months ended October 29, 2022,~~28, 2023, compared to $11.2 million (16.5% effective tax rate) in the six months ended October 30, 2021. The effective tax rate for the six months ended October 29, 2022 was lower than the U.S. statutory tax rate primarily due tonet income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. The effective tax rate for the six months ended October 30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

~~Net income increased $0.1 million, or 0.4%, to~~of $27.6 million in the three months ended October 29, ~~2022, compared to $27.5~~2022. The acquisition of Nordic Lights contributed $0.8 million ~~in the three months ended October 30, 2021. Net income was unfavorably impacted by foreign currency translation~~ of ~~$3.4 million.~~net income. Excluding ~~foreign currency translation,~~Nordic Lights, net income ~~increased $3.5~~decreased $83.7 million as a result of the reasons described above.

~~Net income decreased $7.5 million, or 13.3%, to~~ $49.1 million in the six months ended October 29, ~~2022, compared to $56.6~~2022. The acquisition of Nordic Lights contributed $1.9 million inof net income and the ~~six months ended October 30, 2021. Net income was unfavorably impacted by~~impact of foreign currency translation ~~of $6.3~~was $0.2 million. Excluding Nordic Lights and foreign currency translation, net income decreased ~~$1.2~~$105.4 million as a result of the reasons described above.

Automotive segment net sales ~~increased $0.9~~decreased $42.6 million, or ~~0.5%~~21.6%, to $154.3 million in the three months ended October 28, 2023, compared to $196.9 million in the three months ended October 29, ~~2022, compared to $196.0 million in the three months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $13.2 million.~~2022. Excluding foreign currency translation and customer cost recoveries, net sales ~~increased $15.8~~decreased $42.9 million, or ~~8.2%~~22.0%.

Net sales in North America decreased ~~$1.5~~$26.9 million to $70.9 million in the three months ended October 28, 2023, compared to $97.8 million in the three months ended October 29, ~~2022, compared~~2022. Excluding customer cost recoveries, net sales decreased $25.4 million primarily due to ~~$99.3~~lower sales volumes from program roll-offs. Net sales in EMEA decreased $4.2 million to $49.7 million in the three months ended October 30, 2021. Excluding customer cost recoveries, net sales increased $0.9 million primarily due to higher vehicle lighting product sales volumes, partially offset by lower sales volumes from a major program roll-off. Net sales in EMEA decreased $1.0 million28, 2023, compared to $53.9 million in the three months ended October 29, ~~2022, compared to $54.9 million in the three months ended October 30, 2021.~~2022. The ~~weaker~~stronger euro, relative to the U.S. dollar, ~~decreased~~increased net sales in EMEA by ~~$9.5~~$3.6 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA ~~increased $8.4~~decreased $8.0 million due to lower sales volumes of sensor products, partially offset by higher sales ~~volumes.~~volumes of user interface and switch products. Net sales in Asia ~~increased $3.4~~decreased $11.5 million to $33.7 million in the three months ended October 28, 2023, compared to $45.2 million in the three months ended October 29, ~~2022, compared to $41.8 million in the three months ended October 30, 2021.~~2022. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by ~~$3.6~~$1.4 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales ~~increased $6.4~~decreased $9.5 million ~~primarily~~ due to ~~higher electric vehicle product~~a program roll-off and lower sales volumes ~~partially offset by lower touchscreen sales volumes.~~of overhead consoles.

Automotive segment net sales decreased ~~$18.3~~$60.9 million, or ~~4.7%~~16.3%, to $312.6 million in the six months ended October 28, 2023, compared to $373.5 million in the six months ended October 29, 2022, compared to $391.8 million in the six months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $22.2 million and the roll-off of a major program in North America.2022. Excluding foreign currency translation and customer cost recoveries, net sales decreased ~~$3.4~~$52.3 million, or ~~0.9%~~14.4%.

Net sales in North America decreased ~~$5.9~~$54.8 million to $137.7 million in the six months ended October 28, 2023, compared to $192.5 million in the six months ended October 29, ~~2022, compared~~2022. Excluding customer cost recoveries, net sales decreased $45.4 million primarily due to ~~$198.4~~lower sales volumes from program roll-offs. Net sales in EMEA decreased $4.1 million to $101.9 million in the six months ended October 30, 2021. Excluding customer cost recoveries, net sales decreased $11.3 million primarily due to a major program roll-off, partially offset by higher vehicle lighting product sales volumes. Net sales in EMEA decreased $6.7 million28, 2023, compared to $106.0 million in the six months ended October 29, ~~2022, compared to $112.7 million in the six months ended October 30, 2021.~~2022. The ~~weaker~~stronger euro, relative to the U.S. dollar, ~~decreased~~increased net sales in EMEA by ~~$17.3~~$5.9 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA ~~increased $9.3~~decreased $9.2 million due to lower sales volumes of sensor products, partially offset by higher sales ~~volumes.~~volumes of user interface and switch products. Net sales in Asia decreased ~~$5.7~~$2.0 million to $73.0 million in the six months ended October 28, 2023, compared to $75.0 million in the six months ended October 29, ~~2022, compared to $80.7 million in the six months ended October 30, 2021.~~2022. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by ~~$4.9~~$3.7 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales ~~decreased $1.4~~increased $2.3 million primarily due to ~~COVID-19 lockdowns in China in the first quarter of fiscal 2023.~~higher lead frame sales.

Automotive segment gross profit ~~increased $1.1~~decreased $26.7 million, or ~~3.0%~~69.7%, to $11.6 million in the three months ended October 28, 2023, compared to $38.3 million in the three months ended October 29, ~~2022, compared to $37.2 million in the three months ended October 30, 2021.~~2022. Excluding the impact of foreign currency translation, gross profit ~~increased $4.0~~decreased $27.1 million. Gross profit margins ~~increased~~decreased to 7.5% in the three months ended October 28, 2023, compared to 19.5% in the three months ended October 29, 2022, compared to 19.0% in the three months ended October 30, 2021. The increase in gross profit margins was due to higher sales volumes, which partially offset higher material and other costs due to inflationary pressures.2022.

Automotive segment gross profit decreased ~~$11.2~~$40.8 million, or ~~14.2%~~60.3%, to $26.9 million in the six months ended October 28, 2023, compared to $67.7 million in the six months ended October 29, ~~2022, compared to $78.9 million in the six months ended October 30, 2021.~~2022. Excluding the impact of foreign currency translation, gross profit decreased ~~$6.1~~$41.4 million. Gross profit margins decreased to 8.6% in the six months ended October 28, 2023, compared to 18.1% in the six months ended October 29, ~~2022, compared to 20.1% in the six months ended October 30, 2021.~~ 2022.

The decrease in gross profit margins in both periods was due to lower sales volumes and operational inefficiencies in ~~the first quarter of fiscal 2023, higher material~~North America caused mainly by labor and ~~other costs due~~vendor issues which led to ~~inflationary pressures~~planning deficiencies, inventory shortages, unrecoverable spot purchases and ~~the impact from product mix.~~premium freight, and delayed shipments.

Automotive segment ~~income~~loss from operations ~~decreased $0.2~~was $61.5 million ~~or 0.8%,~~in the three months ended October 28, 2023, compared to income of $23.4 million in the three months ended October 29, ~~2022, compared to $23.6 million~~2022. Loss from operations in the three months ended October ~~30, 2021.~~28, 2023, includes goodwill impairment of $56.5 million. Excluding ~~the impact of foreign currency translation, income from operations increased $1.4 million. The increase was primarily due to higher gross profit, partially offset by higher selling~~goodwill impairment and ~~administrative expenses. Selling and administrative expenses increased due to higher annual cash incentive compensation expense and salary expense as a result of wage inflation.~~

Automotive segment income from operations decreased $12.8 million, or 25.1%, to $38.1 million in the six months ended October 29, 2022, compared to $50.9 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation, income from operations decreased ~~$9.9~~$28.2 million.

Automotive segment loss from operations was $64.3 million in the six months ended October 28, 2023, compared to income of $38.1 million in the six months ended October 29, 2022. Loss from operations in the six months ended October 28, 2023, includes goodwill impairment of $56.5 million. Excluding goodwill impairment and the impact of foreign currency translation, income from operations decreased $45.3 million.

The decrease in both periods was primarily due to lower gross profit and higher selling and administrative expenses. Selling and administrative expenses increased due to higher ~~annual cash incentive compensation~~salary expense, outbound freight expense and ~~salary expense as a result~~restructuring costs, partially offset by lower incentive and stock-based compensation expense.

Industrial segment net sales increased ~~$23.1~~$16.6 million, or ~~28.6%~~16.0%, to $120.4 million in the three months ended October 28, 2023, compared to $103.8 million in the three months ended October 29, ~~2022, compared~~2022. The increase was primarily due to ~~$80.7~~the acquisition of Nordic Lights, which contributed $20.9 million ~~in the three months ended October 30, 2021. Net~~of net sales, ~~were unfavorably impacted by~~and foreign currency translation of ~~$9.0~~$1.3 million, partially offset by lower customer cost recoveries from spot buys of materials and premium freight costs of $2.2 million. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales ~~increased $29.7~~decreased $3.4 million, or ~~36.8%~~3.4%, primarily due to ~~higher~~lower sales volumes of power distribution solutions for data ~~centers and electric vehicles and commercial vehicle lighting solutions products.~~centers.

Industrial segment net sales increased ~~$36.7~~$39.9 million, or ~~23.1%~~20.4%, to $235.8 million in the six months ended October 28, 2023, compared to $195.9 million in the six months ended October 29, ~~2022, compared~~2022. The increase was primarily due to ~~$159.2~~the acquisition of Nordic Lights, which contributed $42.1 million ~~in the six months ended October 30, 2021. Net~~of net sales, ~~were unfavorably impacted by~~and foreign currency translation of ~~$14.3~~$1.8 million, partially offset by lower customer cost recoveries from spot buys of materials and premium freight costs of $3.5 million. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales ~~increased $47.2~~decreased $0.5 million, or ~~29.7%~~0.3%, primarily due to ~~higher~~lower sales volumes of power distribution solutions for data centers, ~~and electric vehicles and~~partially offset by higher sales volumes of commercial vehicle lighting solutions products.

Industrial segment gross profit increased ~~$6.8~~$4.6 million, or ~~25.7%~~13.8%, to $37.9 million in the three months ended October 28, 2023, compared to $33.3 million in the three months ended October 29, ~~2022, compared~~2022. The increase was due to ~~$26.5~~the acquisition of Nordic Lights, which contributed $6.0 million of gross profit, and $0.6 million of favorable foreign currency translation. Excluding the impact of Nordic Lights and foreign currency translation, gross profit decreased $2.0 million. Gross profit margins decreased to 31.5% in the three months ended October ~~30, 2021. Excluding the impact of foreign currency translation, gross profit increased $9.4 million. Gross profit margins decreased~~28, 2023, compared to 32.1% in the three months ended October 29, ~~2022, compared to 32.8% in the three months ended October 30, 2021. Product mix~~2022. Gross profit margins were impacted ~~gross margins due to~~by lower sales volumes and higher material costs for commercial vehicle lighting solutions products, which was partially offset by higher gross margins for power distribution solutions for data centers and electric vehicles due to increased sales volumes.freight expense.

Industrial segment gross profit increased ~~$8.7~~$9.8 million, or ~~15.8%~~15.4%, to $73.5 million in the six months ended October 28, 2023, compared to $63.7 million in the six months ended October 29, ~~2022, compared~~2022. The increase was due to ~~$55.0~~the acquisition of Nordic Lights, which contributed $11.3 million of gross profit, and $0.4 million of favorable foreign currency translation. Excluding the impact of Nordic Lights and foreign currency translation, gross profit decreased $1.9 million. Gross profit margins decreased to 31.2% in the six months ended October ~~30, 2021. Excluding the impact of foreign currency translation, gross profit increased $13.1 million. Gross profit margins decreased~~28, 2023, compared to 32.5% in the six months ended October 29, ~~2022, compared to 34.5% in the six months ended October 30, 2021. Product mix~~2022. Gross profit margins were impacted ~~gross margins primarily from~~by lower sales volumes and higher ~~material costs for commercial vehicle lighting solutions products as a result of supply chain disruptions.~~freight expense.

Industrial segment income from operations increased ~~$6.2~~$0.7 million, or ~~33.0%~~2.8%, to $25.7 million in the three months ended October 28, 2023, compared to $25.0 million in the three months ended October 29, ~~2022, compared~~2022. The increase was due to ~~$18.8~~the acquisition of Nordic Lights, which contributed $1.8 million ~~in the three months ended October 30, 2021.~~of income from operations, and $0.4 million of favorable foreign currency translation. Excluding Nordic Lights and the impact of foreign currency translation, income from operations ~~increased $8.3 million. The increase was primarily~~decreased $1.5 million due to ~~higher~~lower gross profit, partially offset by ~~a slight increase~~lower selling and administrative expenses. The decrease in selling and administrative ~~expenses.~~expenses was primarily due to $0.3 million of restructuring costs recognized in the three months ended October 29, 2022.

Industrial segment income from operations increased ~~$8.4~~$2.5 million, or ~~21.5%~~5.3%, to $49.9 million in the six months ended October 28, 2023, compared to $47.4 million in the six months ended October 29, ~~2022, compared~~2022. The increase was due to ~~$39.0~~the acquisition of Nordic Lights, which contributed $4.0 million ~~in the six months ended October 30, 2021.~~of income from operations, and $0.2 million of favorable foreign currency translation. Excluding Nordic Lights and the impact of foreign currency translation, income from operations ~~increased $12.0~~decreased $1.7 million. The ~~increase~~decrease was primarily due to ~~higher~~lower gross profit, partially offset by ~~a slight increase~~lower selling and administrative expenses. The decrease in selling and administrative ~~expenses.~~expenses was primarily due to $0.4 million of restructuring costs recognized in the six months ended October 29, 2022.

Interface segment net sales decreased ~~$3.9~~$2.4 million, or ~~21.7%~~17.0% to $11.7 million in the three months ended October 28, 2023, compared to $14.1 million in the three months ended October 29, ~~2022, compared to $18.0 million in the three months ended October 30, 2021.~~2022. Excluding customer cost recoveries, net sales decreased ~~$4.6~~$1.3 million, or ~~26.1%~~10.0%. The decrease was primarily due to lower ~~demand~~sales volumes of data solution products, partially offset by higher sales volumes of appliance products.

Interface segment net sales decreased ~~$3.6~~$0.2 million, or ~~11.7%~~0.7%, to $26.9 million in the six months ended October 28, 2023, compared to $27.1 million in the six months ended October 29, ~~2022, compared to $30.7 million in the six months ended October 30, 2021.~~2022. Excluding customer cost recoveries, net sales ~~decreased $4.9~~increased $1.1 million, or ~~16.2%~~4.3%. The ~~decrease~~increase was primarily due to ~~lower demand~~higher sales volumes of appliance products, partially offset by lower sales volumes of data solution products.

Interface segment gross profit decreased ~~$2.5~~$0.6 million, or ~~50.0%~~24.0%, to $1.9 million in the three months ended October 28, 2023, compared to $2.5 million in the three months ended October 29, ~~2022, compared~~2022. Gross profit margins decreased to ~~$5.0 million~~16.2% in the three months ended October ~~30, 2021. Gross profit margins decreased~~28, 2023, compared to 17.7% in the three months ended October 29, ~~2022, compared to 27.8% in the three months ended October 30, 2021.~~2022. The decrease in gross profit margins was primarily due to lower sales volumes.

Interface segment gross profit ~~decreased $2.0~~increased $0.8 million, or ~~29.9%~~17.0%, to $5.5 million in the six months ended October 28, 2023, compared to $4.7 million in the six months ended October 29, ~~2022, compared~~2022. Gross profit margins increased to ~~$6.7 million~~20.4% in the six months ended October ~~30, 2021. Gross profit margins decreased~~28, 2023, compared to 17.3% in the six months ended October 29, ~~2022, compared to 21.8% in the six months ended October 30, 2021.~~2022. The ~~decrease~~increase in gross profit margins was primarily due to ~~lower~~higher sales ~~volumes.~~

Interface segment income from operations decreased ~~$2.8~~$0.6 million, or ~~63.6%~~37.5%, to $1.0 million in the three months ended October 28, 2023, compared to $1.6 million in the three months ended October 29, ~~2022, compared to $4.4 million in the three months ended October 30, 2021.~~2022. The decrease was due to lower gross ~~profit and slightly higher selling and administrative expenses.~~profit.

Interface segment income from operations ~~decreased $2.3~~increased $0.7 million, or ~~41.8%~~21.9%, to $3.9 million in the six months ended October 28, 2023, compared to $3.2 million in the six months ended October 29, ~~2022, compared to $5.5 million in the six months ended October 30, 2021.~~2022. The ~~decrease~~increase was due to ~~lower~~higher gross ~~profit and slightly higher selling and administrative expenses.~~profit.

In the first quarter of fiscal 2024, we made the decision to initiate the discontinuation of the Dabir business (which accounts for all of the Medical segment's financial results). Towards the end of the second quarter of fiscal 2024, we sold certain assets of the Dabir business and have now exited this business.

Medical segment net sales increased ~~$0.3~~$0.5 million to $1.6 million in the three months ended October 28, 2023, compared to $1.1 million in the three months ended October 29, ~~2022, compared to $0.8 million in the three months ended October 30, 2021. The increase was due to higher product acceptance.~~

2022. Medical segment net sales increased ~~$0.2~~$0.6 million to $2.4 million in the six months ended October 28, 2023, compared to $1.8 million in the six months ended October 29, ~~2022, compared~~2022. The increase in both periods was due to ~~$1.6~~last time buys from Dabir's customers.

Medical segment gross profit was $0.6 million in the ~~six~~three months ended October ~~30, 2021. The increase~~28, 2023 compared to a loss of $0.1 million in the three months ended October 29, 2022. Higher gross profit was primarily due to higher ~~product acceptance.~~

~~Gross profit~~sales volumes and lower operating costs. In addition, restructuring costs of $0.2 million were recognized in the three months ended October 28, 2023.

Medical segment gross profit was a loss of $0.1 million in the ~~three~~six months ended October ~~29, 2022~~28, 2023 compared to ~~a loss of $0.4 million in the three months ended October 30, 2021. The improvement was due to higher net sales, partially offset by higher operating costs in the three months ended October 29, 2022.~~

~~Medical segment gross profit was~~ a loss of $0.3 million in the six months ended October 29, ~~2022 compared~~2022. The improvement was due to ~~a loss of $0.4 million~~higher sales volumes in the six months ended October ~~30, 2021. The improvement was due to higher net sales, partially offset by higher operating~~28, 2023. In addition, restructuring costs of $0.8 million were recognized in the six months ended October ~~29, 2022.~~28, 2023.

Medical segment loss from operations decreased ~~$0.4~~$0.7 million to $0.7 million in the three months ended October 28, 2023, compared to $1.4 million in the three months ended October 29, ~~2022, compared to $1.8 million in the three months ended October 30, 2021.~~2022. The decrease in the loss was primarily due to higher gross ~~profit and slightly lower selling and administrative expenses.~~profit.

Medical segment loss from operations ~~decreased $0.1 million to~~was $2.9 million in both the six months ended October 28, 2023 and the six months ended October 29, ~~2022, compared to $3.0 million in the six months ended October 30, 2021. The decrease in the loss was primarily due to higher gross profit.~~2022.

Our liquidity requirements are primarily to fund our business operations, including capital expenditures and working capital requirements, as well as to fund debt service requirements, dividends and stock repurchases. Our primary sources of liquidity are cash flows from operations, existing cash balances and borrowings under our senior unsecured credit agreement. We believe our liquidity position will be sufficient to fund our existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than we expect due to ~~the COVID-19 pandemic,~~ supply chain disruptions, inflationary pressure or other geopolitical risks, including the Russia-Ukraine war and Israel-Hamas war, our liquidity position could be severely impacted.

As of October ~~29, 2022,~~28, 2023, we had ~~$129.6~~$122.5 million of cash and cash equivalents, of which ~~$86.1~~$107.4 million was held in subsidiaries outside the U.S. Cash held by these subsidiaries is used to fund operational activities and can be repatriated, primarily through the payment of dividends and the repayment of intercompany loans, without creating material additional income tax expense.

~~On March 31, 2021, the~~The Board of Directors authorized ~~the~~a program to purchase of up to ~~$100.0~~$200.0 million of our outstanding common ~~stock. On June 16, 2022, the Board of Directors authorized an increase in the existing share buyback program of an additional $100.0 million, and extended the expiration of the program to~~stock through June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October ~~29, 2022,~~28, 2023, a total of ~~2,418,953~~3,113,154 shares have been purchased at a total cost of ~~$102.8~~$127.1 million since the commencement of the share buyback program. As of October ~~29, 2022,~~28, 2023, the dollar value of shares that remained available to be purchased under this share buyback program was ~~$97.2~~$72.9 million.

On October 31, 2022, we entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), with Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits us to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement ~~terminates~~matures on October 31, 2027.

As of October ~~29, 2022, $200.0~~28, 2023, $330.6 million ~~in principal~~ was outstanding under the ~~term loan under the Prior Credit Agreement.~~revolving credit facility. We were in compliance with all covenants under the ~~Prior~~ Credit Agreement as of October ~~29, 2022.~~28, 2023. For further information, see Note 7,8, “Debt” to the condensed consolidated financial statements included in this ~~Quarterly~~ Report.

Net cash used in operating activities was $6.2 million in the six months ended October 28, 2023, compared to net cash provided by operating activities ~~decreased $8.6 million to~~of $28.1 million in the six months ended October 29, ~~2022, compared to $36.7 million in the six months ended October 30, 2021.~~2022. The decrease was due to lower net income adjusted for non-cash items. The ~~$54.0~~$41.7 million of cash outflows for operating assets and liabilities in the six months ended October ~~29, 2022~~28, 2023 was primarily due to higher inventory, prepaid expenses and lower accounts ~~receivable~~payable and ~~inventory,~~other liabilities, partially offset by ~~higher~~lower accounts ~~payable.~~receivable.

Net cash used in investing activities was $22.3 million in the six months ended October 28, 2023, compared to $14.5 million in the six months ended October 29, ~~2022, compared to $20.7~~2022. Capital expenditures were $24.5 million in the six months ended October ~~30, 2021. Capital expenditures were~~28, 2023, compared to $18.0 ~~million and $21.3~~ million in the six months ended October 29, 2022 and October 30, 2021, respectively. We received $3.5 million and $0.6 million of cash from the sale of property, plant and equipment in the six months ended October 29, 2022 and October 30, 2021, respectively.2022.

Net cash provided by financing activities was $1.9 million in the six months ended October 28, 2023, compared to net cash used in financing activities ~~was~~of $48.7 million in the six months ended October 29, ~~2022, compared to $69.7 million in the six months ended October 30, 2021.~~2022. In the six months ended October ~~29, 2022,~~28, 2023, we used ~~$31.6~~$7.8 million of cash for the purchase of shares under our share buyback program, compared to ~~$42.5~~$31.6 million in the six months ended October ~~30, 2021.~~29, 2022. We paid cash dividends of $10.1 million in the six months ended October 28, 2023, compared to $9.9 million in the six months ended October 29, ~~2022,~~2022. In the six months ended October 28, 2023, we had net borrowings of $34.6 million, compared to ~~$10.3~~net repayments of borrowings of $6.5 million in the six months ended October ~~30, 2021.~~29, 2022. In addition, we paid $10.9 million for the ~~six months ended October 29, 2022, we had repayments on our borrowings~~purchase of ~~$6.5 million, compared~~redeemable noncontrolling interests related to ~~$16.8 million in the six months ended October 30, 2021.~~Nordic Lights.

See Note 1, “Description of Business and Summary of Significant Accounting Policies” to the condensed consolidated financial statements included in Item 1.

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. We became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, we terminated all of our agreements with the Fuchs companies. On June 20, 2014, we filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, we amended our complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. We opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal ~~currently is being briefed. No hearing date has yet been set.~~ and the proper course of further proceedings. That briefing was thereafter submitted.

Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that we will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.

In the six months ended October ~~29, 2022~~28, 2023 and October ~~30, 2021,~~29, 2022, we incurred Hetronic-related legal fees of ~~$1.4~~$0.9 million and ~~$3.5~~$0.8 million, respectively. These amounts are included in the selling and administrative expenses in the Industrial segment.

We are exposed to market risks from foreign currency exchange, interest rates, and commodity prices, which could affect our operating results, financial position and cash flows. We manage a portion of these risks through use of derivative financial instruments in accordance with our policies. We do not enter into derivative financial instruments for speculative or trading purposes.

There has been no significant change in our exposure to market risk during the six months ended October ~~29, 2022.~~28, 2023. For a discussion of our exposure to market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in our Annual Report on Form 10-K for the year ended April ~~30, 2022.~~29, 2023.

As of the end of the period covered by this quarterly report on Form 10-Q, we performed an evaluation under the supervision and with the participation of the Company’s management, including our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). ~~The Company’s~~Our disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s applicable rules and forms. As a result of this evaluation, our ~~Chief Executive Officer~~CEO and ~~Chief Financial Officer have~~CFO concluded that ~~as of the end of the period covered by this report, the Company’s~~our disclosure controls and procedures were ~~effective.~~not effective as of October 28, 2023 due to the previously reported material weakness that was disclosed in our Annual Report on Form 10-K for the year ended April 29, 2023.

~~There~~Notwithstanding the identified material weakness, management, including our CEO and CFO, believe that the condensed consolidated financial statements contained in this Quarterly Report fairly present, in all material respects, our financial condition, results of operations and cash flows for the fiscal period presented in conformity with GAAP.

As previously disclosed in our Annual Report on Form 10-K for the year ended April 29, 2023, our management concluded that our internal controls over financial reporting were not effective as of April 29, 2023 due to a material weakness. The material weakness related to revenue at a business unit in our Automotive segment. Specifically, we did not maintain effective review, approval and validation controls over pricing data entered into the business unit's financial system and non-standard contract terms.

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that this material weakness is remediated as soon as possible. We believe we have made progress towards remediation and continue to implement our remediation plan for the material weakness in internal control over financial reporting. Remediation efforts to date include the following:

As we continue to evaluate and work to improve our internal control over financial reporting, management may determine to take additional measures to strengthen controls or to modify the remediation plan described above. When fully implemented and operational, we believe the controls we have designed or plan to design will remediate the control deficiency that has led to the material weakness we have identified and strengthen our internal controls over financial reporting. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Except as described above, there have been no changes in our internal control over financial reporting during the ~~quarter~~three months ended October ~~29, 2022~~28, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Our business, financial condition, results of operations and cash flows are subject to various ‎risks which could cause actual results to vary from recent results or from anticipated future results. There have ‎been no material changes to the risk factors previously disclosed in Part I - Item 1A, “Risk Factors” of our Form 10-K for the ‎year ended April ~~30, 2022.~~29, 2023.‎

~~On March 31, 2021, the~~The Board of Directors authorized ~~the~~a program to purchase of up to ~~$100.0~~$200.0 million of the Company’s outstanding common stock through ~~March 31, 2023. On June 16, 2022, the Board of Directors authorized an increase in the share buyback program of an additional $100.0 million, and extended the expiration of the program to~~ June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October ~~29, 2022,~~28, 2023, we purchased and retired ~~$102.8~~$127.1 million of common stock since the commencement of the share buyback program.

The following table provides information about our purchases of equity securities during the three months ended October ~~29, 2022:~~28, 2023.

During our last fiscal quarter, no director or officer of the Company, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Delaware	36-2090085
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
8750 West Bryn Mawr Avenue, Suite 1000, Chicago, Illinois	60631-3518
(Address of principal executive offices)	(Zip Code)


Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.50 Par Value	MEI	New York Stock Exchange


		Page

PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Consolidated Statements of Income (unaudited) - Three and Six Months Ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022	2

	Condensed Consolidated Statements of Comprehensive Income (unaudited) -Three and Six Months Ended October 28, 2023 and October 29, 2022 ~~and October 30, 2021~~	3

	Condensed Consolidated Balance Sheets as of October ~~29, 2022~~28, 2023 (unaudited) and April ~~30, 2022~~29, 2023	4

	Condensed Consolidated Statements of Shareholders’ Equity (unaudited) - Three and Six Months Ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022	5

	Condensed Consolidated Statements of Cash Flows (unaudited) - Six Months Ended October ~~29, 2022~~28, 2023 and October ~~30, 2021~~29, 2022	7

	Notes to Condensed Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2225

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3235

Item 4.	Controls and Procedures	3235

PART II.	OTHER INFORMATION

Item 1A.	Risk Factors	3337

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3337

Item 5.	Other Information	37

Item 6.	Exhibits	3337

SIGNATURES		3438


☒	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


	As of April 30, 2022
(in millions)	Gross		Accumulated amortization			Net		Weighted average useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	232.3	$	(55.1	)	$	177.2		14.7
Trade names, patents and technology licenses		58.0		(29.3	)		28.7		6.2
Total amortized intangible assets		290.3		(84.4	)		205.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	292.1	$	(84.4	)	$	207.7


Period	Total number of shares purchased		Average price paid per share		Total number of shares purchased as part of publicly announced plan		Approximate dollar value of shares that may yet be purchased under the program (in millions)
July 31, 2022 through August 27, 2022		81,000	$	42.02		81,000	$	113.5
August 28, 2022 through October 1, 2022		361,374	$	38.13		361,374	$	99.7
October 2, 2022 through October 29, 2022		65,805	$	37.68		65,805	$	97.2


Period	Total number of shares purchased1		Average price paid per share		Total number of shares purchased as part of publicly announced plan		Approximate dollar value of shares that may yet be purchased under the program (in millions)
July 30, 2023 through August 26, 2023		—	$	—		—	$	80.7
August 27, 2023 through September 30, 2023		34,744	$	21.6		34,744	$	79.9
October 1, 2023 through October 28, 2023		288,035	$	24.3		288,035	$	72.9

(1) In addition to open-market purchases, 193 shares of common stock were surrendered by employees to satisfy tax withholding obligations in connection with the vesting of restricted stock units.


Exhibit Number		Description
10.1**		Retention, Transition Services and Consulting Agreement between the Company and Donald W. Duda dated August 31, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on August 31, 2023).
~~10.1~~10.2**		~~Methode Electronics, Inc. 2022 Omnibus Incentive Plan~~Form of Retention Bonus Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on September ~~14, 2022)~~18, 2023).
31.1		Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
31.2		Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32*		Certification of Periodic Financial Report Pursuant to 18 U.S.C. Section 1350.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


*		Indicates that the exhibit is being furnished with this report and not filed as part of it.
**		Management compensatory plan.


		METHODE ELECTRONICS, INC.

		By:	/s/ Ronald L.G. Tsoumas
			Ronald L.G. Tsoumas
			Chief Financial Officer
			(Principal Financial Officer)

Dated:	December ~~1, 2022~~7, 2023

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company